$BTI

BTI Q2 2026 Earnings Call Transcript

British American Tobacco (BTI) Q2 2026 earnings call reported 2.9% group revenue growth at constant currency and a 7.9% rise in adjusted diluted EPS. New Category revenue grew 18%, with Modern Oral up 66%. Smokeless was 19.8% of revenue. Full-year EPS guidance was upgraded to the mid of 5% to 8%, with GBP 1.3bn buyback for 2026 and Fit2Win savings of GBP 700m by 2028.

Original reporting
Published Aug 4, 2026, 12:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BTI Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$BTIBullishMed
01

Why it matters

Traders can update models for BTI based on the upgraded full-year EPS range, revised net finance cost expectations, and explicit capital return and leverage targets.

02

Market read

The transcript provides concrete guidance and balance-sheet/capital allocation updates that can drive near-term repricing of BTI’s earnings outlook.

03

What to watch

Fit2Win transformation includes one-off costs (GBP 950M) and manufacturing asset upgrade charges (GBP 230M non-cash), which could complicate near-term cash flow quality versus headline EPS.

Relevance 8/10Novelty 7/10Timing: pre-market today, following the Q2 2026 earnings call transcript

Background

BTI management discusses progress on its Fit2Win transformation, smokeless growth, and regional performance during the Q2 2026 earnings call transcript.

Company-level read

Ticker impact

$BTIBullishMedium confidence
Context

British American Tobacco upgraded full-year EPS guidance to the middle of a 5% to 8% range, citing lower net finance costs and cash conversion.

Expected impact

Moderate upside bias into the next trading sessions as traders price in improved EPS outlook and lower finance-cost drag.

Evidence & confidence

The transcript includes specific, decision-relevant updates: upgraded EPS range, expected net finance costs of about GBP 1.65B, and a 2026 buyback allocation of GBP 1.3B with a stated leverage target.

Market effects

Reinforces the market narrative that smokeless and modern oral categories are gaining share, while heated products face competitive pressure in value segments.

Highlights APMEA headwinds tied to regulation and illicit volume, versus relative resilience in AME and improving U.S. legal vapour enforcement.

Supports broader tobacco sector expectations for margin expansion from transformation programs and debt repayment-driven finance-cost relief.

Counterpoint

The guidance upgrade may be partially offset by ongoing heated-product declines and APMEA regulatory/illicit-volume uncertainty, limiting how durable the margin expansion is.

Key entities

  • British American Tobacco p.l.c.

    Subject of the earnings call transcript, providing guidance upgrades, segment performance updates, and capital allocation details.

  • Tadeu Marroco

    CEO who highlighted U.S. vapour enforcement-driven legal market growth and upcoming Velo Max launch.

  • Javed Iqbal

    Interim CFO who discussed financial performance drivers including lower net finance costs and transformation savings.

Related articles

$PMMed

Philip Morris (PM) Bets $1.2B on ZYN as BAT (BTI) Steps Up Its Pouch Push

Philip Morris International (PM) opened a $1.2B, 780,000 sq ft Aurora, Colorado campus to produce ZYN nicotine pouches, after about 19 months. The FDA authorized 20 ZYN products as modified risk tobacco products on June 30. Reuters also cited PM beating Q2 estimates. The article notes Aurora cost rose from $600M and highlights BAT (BTI) growth and planned Velo Max rollout.

$BTIMedAI 8/10

BRITISH AMERICAN TOBACCO PLC – British American Tobacco Announces Pricing of $1,500,000,000 Notes Offerings - Sens

British American Tobacco (BAT) said its wholly owned subsidiary B.A.T. Capital Corporation priced a $1.5 billion notes offering. It includes $750 million 5.300% notes due 2033 and $750 million 5.550% notes due 2036, guaranteed by BAT and other entities including Reynolds American Inc. Expected to close 5 Aug 2026. Net proceeds for general corporate purposes, including potential debt repayment.

$BTIMed

BTI Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Tadeu Marroco Interim Chief Financial Officer - Javed Iqbal Group Head of Investor Relations - Victoria Buxton TAKEAWAYS Group Revenue -- 2.9% growth at constant currency, reflecting multi-category performance in the U.S. and an acceleration in New Category growth. Adjusted Diluted EPS -- 7.9% increase, supported by lower net finance costs following debt repayment and 4.4% growth from earning kickers.

$BTIMed

BAT Lifts Annual Profit Growth Target As Velo Drives US Momentum

British American Tobacco (BAT) raised its full-year adjusted EPS growth outlook to the middle of its 5% to 8% medium-term range, up from earlier guidance at the low end, citing strong US momentum and demand for its Velo nicotine pouches, offsetting weaker Asia. It kept revenue and adjusted operating profit growth at the low end of 3% to 5% and 4% to 6%. Six-month adjusted EPS was 164p, up 7.9% vs a 158.5p consensus.

$BTIMed

BAT must face class-action litigation over cigarette labels, US appeals court rules By Reuters

A divided U.S. appeals court ruled British American Tobacco’s Natural American Spirit cigarette labeling claims can proceed as class actions. The 10th Circuit upheld certification of menthol-related claims and set aside denial of “safer cigarette” claims, allowing consumers in 12 states to seek damages. Reuters reports the case was returned to a district judge for further proceedings.